NRX PHARMACEUTICALS INC (NRXP) Stock Balance Sheet
NASDAQ:NRXP - Nasdaq - US6294442099 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.55M | 1.44M | 4.59M | 20.05M | 27.61M | |||
| Other Current Assets | 1.71M | 1.86M | 2.29M | 5.74M | 5.11M | |||
| Total Current Assets | 7.26M | 3.30M | 6.88M | 25.80M | 32.71M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 10.00K | N/A | N/A | N/A | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 334.00K | 339.00K | 431.00K | 21.00K | 15.00K | |||
| Total Non-Current Assets | 334.00K | 349.00K | 431.00K | 21.00K | 15.00K | |||
| TOTAL ASSETS | 7.59M | 3.65M | 7.32M | 25.82M | 32.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 320.00K | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 8.40M | 1.25M | 9.16M | 7.70M | 518.00K | |||
| Accrued Expenses | 1.42M | 1.70M | 4.63M | 4.51M | 1.63M | |||
| Accounts Payable | 4.31M | 4.13M | 4.63M | 2.08M | 3.69M | |||
| Other Current Liabilities | 18.62M | 14.46M | 622.00K | 1.29M | 6.09M | |||
| Total Current Liabilities | 32.75M | 21.86M | 19.05M | 15.59M | 11.92M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 5.01M | 0.00 | 2.82M | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 5.01M | 0.00 | 2.82M | 0.00 | |||
| TOTAL LIABILITIES | 32.75M | 26.87M | 19.05M | 18.41M | 11.92M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -283.79M | -278.27M | -253.15M | -223.00M | -183.24M | |||
| Additional Paid In Capital | 258.61M | 255.03M | 241.33M | 230.34M | 203.99M | |||
| Common Shares | 17.00K | 15.00K | 87.00K | 67.00K | 59.00K | |||
| Other Shareholders' Equity | N/A | 0.00 | -3.00K | N/A | N/A | |||
| Shares Outstanding | 17.12M | 14.59M | 83.92M | 6.64M | 5.88M | |||
| Tangible Book Value per Share | -1.47 | -1.59 | -0.14 | 1.12 | 3.54 | |||
| Total Shareholders' Equity | -25.16M | -23.22M | -11.73M | 7.41M | 20.81M | |||
| TOTAL LIABILITIES AND EQUITY | 7.59M | 3.65M | 7.32M | 25.82M | 32.73M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -0.23 | N/A | 0.38 | N/A | |||
| Current Ratio | 0.22 | 0.15 | 0.36 | 1.66 | 2.74 | |||
| Return On Assets (ROA) | -317.65% | -688.20% | -412.29% | -153.99% | -1065.98% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -536.56% | -1676.85% | |||
All data in USD , ROIC based on taxRate of 0.21